Non-lytic viral immunotherapy induces long-term glioblastoma survival and tumor-specific immunity without eliciting an antiviral response

Engineered immunotherapy drug eliminates aggressive metastatic cancers in clinical trial

Researchers at Rockefeller University have developed an engineered CD40 agonist antibody that successfully eliminated aggressive metastatic

Programming the immunological properties of mRNA vaccines for cancer

CD4+ T cells and macrophages collaborate to cut off tumor blood supply via IL-3 and TNF signaling

This study by Lian et al. reveals a novel mechanism by which CD4+ T cells and macrophages collaborate to impair tumor growth. CD4+ T cells r

Columbia Researcher Discovers Rare Genetic Mutation That Provides Universal Antiviral Immunity

Columbia University immunologist Dusan Bogunovic discovered that a rare genetic mutation causing immune deficiency in some patients also gra

Scientists Develop Universal Cancer Vaccine Using mRNA Technology

Scientists have developed a 'universal cancer vaccine' using mRNA technology that can train the immune system to target any type of cancer,

Efficient mRNA delivery to resting T cells to reverse HIV latency